Biotech | March 07, 2024
Biomanufacturing and Bio-foundry will drive India’s future bioeconomy: Dr. Jitendra Singh
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
The validations confirm the completion of the applications and commence the scientific review process
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
The acquisition will build on AstraZeneca’s expertise in respiratory syncytial virus
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
Exblifeb demonstrates remarkable efficacy in treating complicated Urinary Tract Infections (cUTI), pneumonia
Union Ayush Minister with Assam Chief Minister lays foundation stone for Central Research Institute of Yoga & Naturopathy
Pivotal trial found the enfortumab vedotin plus pembrolizumab combination significantly extended overall and progression-free survival
Subscribe To Our Newsletter & Stay Updated
